Literature DB >> 33616676

PAX5 activates telomerase activity and proliferation in keloid fibroblasts by transcriptional regulation of SND1, thus promoting keloid growth in burn-injured skin.

Gaoping Qin1, Yaowen Sun1, Yadong Guo1, Yong Song2.   

Abstract

OBJECTIVE: Staphylococcal nuclease domain-containing 1 (SND1) that functioned as an oncogene in a variety of tumors was upregulated in burn-injured skin tissues, and this study aims to investigate the effect of SND1 on keloid and elucidate the underlying mechanism.
METHODS: Keloid fibroblasts (KFs) and normal skin fibroblasts (NFs) were isolated from the keloid tissues and adjacent normal skin tissues of keloid patients. The SND1 expression was assessed in keloid tissues and KFs with Western blot assay. Gain- and loss-of-function experiments were performed to investigate the role of SND1 in proliferation, colony formation, telomerase activity, expression of fibrogenic genes and production of pro-inflammatory factors in KFs. Chromatin immunoprecipitation (CHIP) and Dual-luciferase reporter gene assays were used to verify the interaction of Paired-box gene 5 (PAX5) on SND1 promoter. Then, a series of rescue experiments were performed to verify the effects of SND1 overexpression on PAX5 knockdown-mediated KF functions. Finally, the role of SND1 in keloid formation in vivo was validated in mice with keloid implantation.
RESULTS: SND1 was upregulated in keloid tissues and KFs. SND1 positively regulated proliferation, colony formation, telomerase activity, production of pro-inflammatory factors and expression of fibrogenic genes. PAX5 directly bound to the SND1 promoter to transcriptionally regulate SND1 expression and positively regulated SND1-mediated KF functions via the ERK/JNK pathway. In vivo assay further demonstrated that SND1 displayed a positive effect on keloid formation.
CONCLUSION: SND1 transcriptionally regulated by PAX5 promotes keloid formation through activating telomerase activity via the ERK/JNK signaling pathways, which provides a promising therapeutic target for clinical treatment of burned skin keloid.

Entities:  

Keywords:  Burn; Keloid; PAX5; SND1; Telomerase activity; Transcriptional regulation

Year:  2021        PMID: 33616676     DOI: 10.1007/s00011-021-01444-3

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  3 in total

1.  Effects of hTERT antisense oligodeoxynucleotide on cell apoptosis and expression of hTERT and bcl-2 mRNA in keloid fibroblasts.

Authors:  Y Huang; L-X Lin; Q-X Bi; P Wang; X-M Wang; J Liu; Y-T Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-04       Impact factor: 3.507

2.  B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.

Authors:  Cheng-Der Liu; Hsueh-Ling Lee; Chih-Wen Peng
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

3.  Diagnostic utility of PAX2 and PAX5 in distinguishing non-small cell lung cancer from small cell lung cancer.

Authors:  Yinlong Ren; Junna Hou; Aiguo Xu; Yunbao Pan
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.